Outbreak of Legionnaires' disease among cruise ship passengers exposed to a contaminated whirlpool spa.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMID 8596266)

Published in Lancet on February 24, 1996

Authors

D B Jernigan1, J Hofmann, M S Cetron, C A Genese, J P Nuorti, B S Fields, R F Benson, R J Carter, P H Edelstein, I C Guerrero, S M Paul, H B Lipman, R Breiman

Author Affiliations

1: Childhood and Respiratory Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles citing this

Legionella and Legionnaires' disease: 25 years of investigation. Clin Microbiol Rev (2002) 7.42

A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999. Emerg Infect Dis (2002) 3.24

Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev (2015) 1.41

Legionnaires' disease at a Dutch flower show: prognostic factors and impact of therapy. Emerg Infect Dis (2002) 1.41

Single clonal origin of a high proportion of Legionella pneumophila serogroup 1 isolates from patients and the environment in the area of Paris, France, over a 10-year period. J Clin Microbiol (1999) 1.31

Increased rainfall is associated with increased risk for legionellosis. Epidemiol Infect (2006) 1.27

Restaurant outbreak of Legionnaires' disease associated with a decorative fountain: an environmental and case-control study. BMC Infect Dis (2007) 1.04

Outbreak of Legionnaires' disease on a cruise ship linked to spa-bath filter stones contaminated with Legionella pneumophila serogroup 5. Epidemiol Infect (2006) 0.99

Legionella species colonization of water distribution systems, pools and air conditioning systems in cruise ships and ferries. BMC Public Health (2008) 0.95

Prevalence study of Legionella spp. contamination in ferries and cruise ships. BMC Public Health (2006) 0.94

The role of arbitrarily primed PCR in identifying the source of an outbreak of Legionnaires' disease. J Clin Microbiol (1997) 0.87

Evaluation of an Optimal Epidemiological Typing Scheme for Legionella pneumophila with Whole-Genome Sequence Data Using Validation Guidelines. J Clin Microbiol (2016) 0.85

Uncertainties associated with assessing the public health risk from Legionella. Front Microbiol (2014) 0.84

Public health and economic costs of investigating a suspected outbreak of Legionnaires' disease. Epidemiol Infect (2007) 0.82

Legionnaires' disease outbreak associated with a cruise liner, August 2003: epidemiological and microbiological findings. Epidemiol Infect (2006) 0.82

Legionella on board trains: effectiveness of environmental surveillance and decontamination. BMC Public Health (2012) 0.79

Aerosolization of respirable droplets from a domestic spa pool and the use of MS-2 coliphage and Pseudomonas aeruginosa as markers for Legionella pneumophila. Appl Environ Microbiol (2014) 0.77

Airborne biological hazards and urban transport infrastructure: current challenges and future directions. Environ Sci Pollut Res Int (2016) 0.75

From Evolutionary Advantage to Disease Agents: Forensic Reevaluation of Host-Microbe Interactions and Pathogenicity. Microbiol Spectr (2017) 0.75

Articles by these authors

Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens. J Clin Microbiol (1981) 11.09

Four serogroups of Legionnaires' disease bacteria defined by direct immunofluorescence. Ann Intern Med (1979) 7.89

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 5.60

The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med (1995) 5.18

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med (1997) 4.84

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis (2001) 4.79

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science (1986) 4.44

Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire. Am J Trop Med Hyg (1995) 4.32

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet (1997) 4.11

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.07

New insights to the MLL recombinome of acute leukemias. Leukemia (2009) 4.07

Laboratory diagnosis of Legionnaires' disease. Am Rev Respir Dis (1980) 3.95

Use of a semiselective medium to culture Legionella pneumophila from contaminated lung specimens. J Clin Microbiol (1979) 3.86

Legionella longbeachae species nova, another etiologic agent of human pneumonia. Ann Intern Med (1981) 3.78

Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med (1992) 3.64

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA (1993) 3.31

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis (1997) 3.29

The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis (1996) 3.26

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet (2001) 3.21

Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis (1999) 3.15

Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum (2001) 3.14

Proliferation of Legionella pneumophila as an intracellular parasite of the ciliated protozoan Tetrahymena pyriformis. Appl Environ Microbiol (1984) 3.02

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A (2001) 2.95

The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum (1998) 2.92

Legionella pneumophila mip gene potentiates intracellular infection of protozoa and human macrophages. Proc Natl Acad Sci U S A (1992) 2.87

Association of shower use with Legionnaires' disease. Possible role of amoebae. JAMA (1990) 2.87

Immunologic diagnosis of Legionnaires' disease: cross-reactions with anaerobic and microaerophilic organisms and infections caused by them. J Infect Dis (1980) 2.76

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71

Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern Med (1994) 2.70

Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis (2001) 2.68

Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol (2001) 2.68

Rapid radioimmunoassay diagnosis of Legionnaires' disease: detection and partial characterization of urinary antigen. Ann Intern Med (1981) 2.60

The MLL recombinome of acute leukemias in 2013. Leukemia (2013) 2.55

Isolation of protozoa from water associated with a legionellosis outbreak and demonstration of intracellular multiplication of Legionella pneumophila. Appl Environ Microbiol (1986) 2.52

Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci U S A (1991) 2.50

Susceptibility of Legionella pneumophila to twenty antimicrobial agents. Antimicrob Agents Chemother (1980) 2.49

Legionnaires' disease: unusual clinical and laboratory features. Ann Intern Med (1980) 2.46

Neurosteroids act on recombinant human GABAA receptors. Neuron (1990) 2.44

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (1999) 2.43

Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41

Comparative study of selective media for isolation of Legionella pneumophila from potable water. J Clin Microbiol (1982) 2.38

Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorrhoeae entry into human mucosal cells. EMBO J (1995) 2.37

Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. J Neurosci (1985) 2.37

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol (1997) 2.35

Paleoepidemiologic investigation of Legionnaires disease at Wadsworth Veterans Administration Hospital by using three typing methods for comparison of legionellae from clinical and environmental sources. J Clin Microbiol (1986) 2.34

Brief report: malaria probably locally acquired in New Jersey. N Engl J Med (1994) 2.32

Growth-supporting activity for Legionella pneumophila in tap water cultures and implication of hartmannellid amoebae as growth factors. Appl Environ Microbiol (1988) 2.32

Inappropriate testing for diarrheal diseases in the hospital. JAMA (1990) 2.31

Rapid diagnosis of Legionnaires' disease by urinary antigen detection. Comparison of ELISA and radioimmunoassay. Am J Med (1982) 2.30

Comparison of guinea pig and protozoan models for determining virulence of Legionella species. Infect Immun (1986) 2.28

Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med (1996) 2.27

Isolation of a new serotype of legionnaires' disease bacterium. Lancet (1978) 2.21

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J Clin Invest (1999) 2.21

Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann Neurol (2000) 2.21

Outbreak of Pontiac fever due to Legionella anisa. Lancet (1990) 2.20

Hospital characteristics associated with colonization of water systems by Legionella and risk of nosocomial legionnaires' disease: a cohort study of 15 hospitals. Infect Control Hosp Epidemiol (1999) 2.20

Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci U S A (1996) 2.18

Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs. Am Rev Respir Dis (1984) 2.18

Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr (1996) 2.17

Legionella pneumophila serogroup Lansing 3 isolated from a patient with fatal pneumonia, and descriptions of L. pneumophila subsp. pneumophila subsp. nov., L. pneumophila subsp. fraseri subsp. nov., and L. pneumophila subsp. pascullei subsp. nov. J Clin Microbiol (1988) 2.06

Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci U S A (1998) 2.00

Isolation of Legionella pneumophila from blood. Lancet (1979) 1.97

Evaluation of the Gen-Probe DNA probe for the detection of legionellae in culture. J Clin Microbiol (1986) 1.95

Legionella birminghamensis sp. nov. isolated from a cardiac transplant recipient. J Clin Microbiol (1987) 1.94

Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis (1995) 1.93

Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group. Clin Infect Dis (1995) 1.91

Effects of cytochalasin D and methylamine on intracellular growth of Legionella pneumophila in amoebae and human monocyte-like cells. Infect Immun (1991) 1.88

Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci (1999) 1.86

Tracking epidemic Chikungunya virus into the Indian Ocean from East Africa. J Gen Virol (2008) 1.86

Legionella wadsworthii species nova: a cause of human pneumonia. Ann Intern Med (1982) 1.85

Legionella moravica sp. nov. and Legionella brunensis sp. nov. isolated from cooling-tower water. Ann Inst Pasteur Microbiol (1988) 1.84

Comparison of arbitrarily primed polymerase chain reaction, ribotyping, and monoclonal antibody analysis for subtyping Legionella pneumophila serogroup 1. J Clin Microbiol (1993) 1.82

Legionnaires' disease. Postmortem pathologic findings of 20 cases. Am J Clin Pathol (1980) 1.82

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol (1997) 1.82

Legionella tucsonensis sp. nov. isolated from a renal transplant recipient. J Clin Microbiol (1989) 1.80

Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group. JAMA (1996) 1.79

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology (2000) 1.76

Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science (1980) 1.76

Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J Neurosci (2000) 1.75

Legionnaires' disease in renal-transplant recipients. Lancet (1978) 1.75

Isolation of Legionella pneumophila from a transtracheal aspirate. J Clin Microbiol (1979) 1.74

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA (1997) 1.74

Biliary complications in the treatment of unsubstantiated Lyme disease. J Infect Dis (1995) 1.74

Outbreak of Salmonella serotype Hartford infections associated with unpasteurized orange juice. JAMA (1998) 1.71

Role of biofilms in the survival of Legionella pneumophila in a model potable-water system. Microbiology (2001) 1.69

Susceptibility of Legionella spp. to mycinamicin I and II and other macrolide antibiotics: effects of media composition and origin of organisms. Antimicrob Agents Chemother (1982) 1.68

Retrospective study of Gen-Probe rapid diagnostic system for detection of legionellae in frozen clinical respiratory tract samples. J Clin Microbiol (1987) 1.65

Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev (2000) 1.61

A randomized trial of exercise and dietary counseling after liver transplantation. Am J Transplant (2006) 1.61

11th serogroup of Legionella pneumophila isolated from a patient with fatal pneumonia. J Clin Microbiol (1986) 1.61

Comparison of slide agglutination test and direct immunofluorescence assay for identification of Legionella isolates. J Clin Microbiol (1983) 1.59

Potable water as a source of Legionnaires' disease. JAMA (1985) 1.56

A genome-wide search for chromosomal loci linked to bipolar affective disorder in the Old Order Amish. Nat Genet (1996) 1.56

Mapping quantitative trait loci for open-field behavior in mice. Behav Genet (1997) 1.54

Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results. Arch Gen Psychiatry (1988) 1.53

Physical functioning and health-related quality-of-life changes with exercise training in hemodialysis patients. Am J Kidney Dis (2000) 1.53